Cargando…
Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis
The potent antimalarial drug pyronaridine (PND) was tested for its potential as an anticancer drug. After exposing cancerous (17) and non-cancerous (2) cells to PND for 72 hr, PND was found to exhibit consistent and potent cytotoxic activity at low micromolar (μM) concentrations that ranged from 1.6...
Autores principales: | Villanueva, Paulina J., Martinez, Alberto, Baca, Sarah T., DeJesus, Rebecca E., Larragoity, Manuel, Contreras, Lisett, Gutierrez, Denisse A., Varela-Ramirez, Armando, Aguilera, Renato J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218039/ https://www.ncbi.nlm.nih.gov/pubmed/30395606 http://dx.doi.org/10.1371/journal.pone.0206467 |
Ejemplares similares
-
Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways
por: Gutierrez, Denisse A., et al.
Publicado: (2022) -
Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro
por: Hess, Jessica D., et al.
Publicado: (2022) -
Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol
por: Morris, Carrie A., et al.
Publicado: (2014) -
Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016) -
Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)